Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Apyx Medical Corp (APYX)  
$1.45 0.03 (2.03%) as of 4:30 Fri 4/26


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 34,270,000
Market Cap: 49.69(M)
Last Volume: 129,549 Avg Vol: 129,187
52 Week Range: $1.25 - $7.59
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 7.2
Insider 3/6 Months : 7.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Apyx Medical is an energy technology company. In its Advanced Energy segment, Co.'s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Co.'s primary focus is on the cosmetic surgery market where Renuvion® provides plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue. In its Original Equipment Manufacturing (OEM) segment, Co. produces generators and related accessories for medical device manufacturers through OEM agreements, as well as start-up companies with the need for its energy-based designs.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 52,500 52,500 64,250
Total Buy Value $0 $83,975 $83,975 $154,043
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 2 3
Total Shares Sold 0 0 30,000 30,000
Total Sell Value $0 $0 $226,800 $226,800
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 36
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hill Mathew C Chief Financial Officer   •       –      –    2023-12-12 4 B $2.19 $5,475 D/D 2,500 2,500 2.74 -31%     
   Goodwin Charles D. Ii Chief Executive Officer   •       •      –    2023-11-14 4 B $1.57 $78,500 D/D 50,000 90,000 2.81 -15%     
   Waldman Lawrence Director   –       •      –    2023-07-12 4 OE $2.97 $15,854 I/I 5,338 5,338     -
   Hornsby Todd Executive Vice President   •       –      –    2023-06-26 4/A AS $7.56 $113,400 D/D (15,000) 0     -
   Hornsby Todd Executive Vice President   •       –      –    2023-06-26 4 AS $7.56 $113,400 D/D (15,000) 40 -69%     
   Hornsby Todd Executive Vice President   •       –      –    2023-06-26 4 OE $1.77 $26,550 D/D 15,000 15,000     -
   Geraghty Michael Director   –       •      –    2023-06-06 4 OE $2.79 $27,900 D/D 10,000 27,500     -
   Goodwin Charles D. Ii Chief Executive Officer   •       •      –    2022-08-29 4 B $5.93 $70,068 D/D 11,750 40,000 2.81 -57%     
   Citronowicz Moshe Sr. V.P. of Operations   •       –      –    2022-07-11 4 OE $2.54 $76,200 D/D 30,000 456,504     -
   Waldman Lawrence Director   –       •      –    2022-07-11 4 OE $2.54 $60,960 D/D 24,000 37,563     -
   Geraghty Michael Director   –       •      –    2022-07-06 4 OE $2.54 $10,160 D/D 4,000 17,500     -
   Makrides Andrew Director   –       •      –    2022-07-05 4 D $6.14 $83,400 D/D (13,583) 624,389     -
   Makrides Andrew Director   –       •      –    2022-07-05 4 OE $2.54 $76,200 D/D 30,000 637,972     -
   Waldman Lawrence Director   –       •      –    2022-05-19 4 OE $2.79 $22,320 D/D 8,000 13,563     -
   Geraghty Michael Director   –       •      –    2022-05-11 4 OE $2.79 $16,740 D/D 6,000 13,500     -
   Swandal Craig A. Director   –       •      –    2022-03-21 4 OE $4.98 $84,660 D/D 17,000 17,000     -
   Swandal Craig A. Director   –       •      –    2022-01-07 4 OE $9.42 $67,570 D/D 7,173 60,173     -
   Waldman Lawrence Director   –       •      –    2021-03-08 4 OE $2.81 $15,632 D/D 5,563 5,563     -
   Geraghty Michael Director   –       •      –    2021-03-05 4 OE $2.81 $21,075 D/D 7,500 7,500     -
   Goodwin Charles D. Ii Chief Executive Officer   •       •      –    2020-05-13 4 B $3.30 $93,197 D/D 28,250 28,250 2.81 33%     
   Swandal Craig A. Director   –       •      –    2019-10-01 4 OE $5.30 $53,000 D/D 10,000 36,000     -
   Swandal Craig A. Director   –       •      –    2019-04-04 4 A $5.30 $31,800 D/D 6,000 26,000     -
   Swandal Craig A. Director   –       •      –    2019-04-04 4 OE $2.37 $4,740 D/D 2,000 20,000     -
   Swandal Craig A. Director   –       •      –    2019-01-10 4 OE $2.37 $66,100 D/D 18,000 18,000     -
   Makrides Andrew Director   –       •      –    2018-11-08 4 GD $6.84 $41,040 D/D 6,000 605,972     -

  36 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed